Abstract
Background: Sunitinib (SU11248) is an oral multi-target tyrosine kinase inhibitor (TKI) with low molecular weight, that inhibits platelet-derived grow......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
